Cogniciti is the brain health subsidiary of Toronto-based Baycrest Health Sciences. Since its launch in 2014, Cogniciti’s Online Brain Health Assessment has shown exceptional user engagement, with over 63,000 assessments completed. Cogniciti aims to bring brain health solutions to people, businesses, and governments worldwide.
To do this, we offer free brain health workshops at senior’s centres, recruit for promising mild cognitive impairment (MCI) clinical research studies, and compile a vast research registry of motivated adults across Canada, the US and the UK.
Now in its 100th year of operation, Baycrest Health Sciences is an established global leader in geriatric healthcare, research, innovation and education. It is Canada’s largest geriatric hospital, North America’s largest geriatrics training institute, and a world leader in the research of memory and aging. It is also home to the Rotman Research Institute, one of the world’s leaders in cognitive neuroscience.
MaRS Discovery District in Toronto is a Canadian leader in converting science and technology research into practical solutions. It is one of the world’s largest urban innovation hubs supporting a new generation of makers and innovators who aim to create solutions that address key societal challenges. In the last three years, MaRS ventures have raised $1.3 billion in capital and earned $640 million in revenue.
Cambridge Brain Sciences (CBS) is a world leader in providing scientifically proven web-based tools for the assessment of cognitive function.
The CBS concept was developed by Doctors Adrian Owen and Adam Hampshire during their time at the MRC Cognition and Brain Sciences Unit in Cambridge England. CBS has since moved to the Brain and Mind Institute at Western University in London Ontario Canada where development of web-based assessment platforms is focused in two areas: a) scientific investigation including clinical and pharmaceutical trials and b) tools that allow members of the public to assess their memory, attention, reasoning and planning. More than 200,000 CBS assessments have been completed on adults across the globe and dozens of research trials are currently taking place using the CBS platform.